233 related articles for article (PubMed ID: 25012730)
1. Clinical and economic burden in patients with diagnosis of peripheral arterial disease in a claims database in Japan.
Hosaka A; Miyata T; Onishi Y; Liao L; Zhang Q
Clin Ther; 2014 Aug; 36(8):1223-30, 1230.e1-4. PubMed ID: 25012730
[TBL] [Abstract][Full Text] [Related]
2. Comparative Assessment of Medical Resource Use and Costs Associated with Patients with Symptomatic Peripheral Artery Disease in the United States.
Chase MR; Friedman HS; Navaratnam P; Heithoff K; Simpson RJ
J Manag Care Spec Pharm; 2016 Jun; 22(6):667-75. PubMed ID: 27231794
[TBL] [Abstract][Full Text] [Related]
3. Impact of cardiovascular disease on health care economic burden and resource utilization: a retrospective cohort study in adults in the United States with type 2 diabetes with or without stroke, myocardial infarction, and peripheral arterial disease.
King A; Rajpura J; Liang Y; Paprocki Y; Uzoigwe C
Curr Med Res Opin; 2022 Nov; 38(11):1831-1840. PubMed ID: 36134459
[TBL] [Abstract][Full Text] [Related]
4. Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.
Emery C; Torreton E; Briere JB; Evers T; Fagnani F
J Med Econ; 2020 May; 23(5):513-520. PubMed ID: 31928390
[No Abstract] [Full Text] [Related]
5. Economic burden of irritable bowel syndrome with constipation: a retrospective analysis of health care costs in a commercially insured population.
Doshi JA; Cai Q; Buono JL; Spalding WM; Sarocco P; Tan H; Stephenson JJ; Carson RT
J Manag Care Spec Pharm; 2014 Apr; 20(4):382-90. PubMed ID: 24684643
[TBL] [Abstract][Full Text] [Related]
6. Healthcare resource utilization and costs in working-age patients with high-risk atherosclerotic cardiovascular disease: findings from a multi-employer claims database.
Zhao Z; Zhu Y; Fang Y; Ye W; McCollam P
J Med Econ; 2015; 18(9):655-65. PubMed ID: 25891183
[TBL] [Abstract][Full Text] [Related]
7. Health care resources and costs for treating peripheral artery disease in a managed care population: results from analysis of administrative claims data.
Margolis J; Barron JJ; Grochulski WD
J Manag Care Pharm; 2005; 11(9):727-34. PubMed ID: 16300416
[TBL] [Abstract][Full Text] [Related]
8. The Contribution of Tobacco Use to High Health Care Utilization and Medical Costs in Peripheral Artery Disease: A State-Based Cohort Analysis.
Duval S; Long KH; Roy SS; Oldenburg NC; Harr K; Fee RM; Sharma RR; Alesci NL; Hirsch AT
J Am Coll Cardiol; 2015 Oct; 66(14):1566-1574. PubMed ID: 26429081
[TBL] [Abstract][Full Text] [Related]
9. Long-term cardiovascular outcome, use of resources, and healthcare costs in patients with peripheral artery disease: results from a nationwide Swedish study.
Hasvold P; Nordanstig J; Kragsterman B; Kristensen T; Falkenberg M; Johansson S; Thuresson M; Sigvant B
Eur Heart J Qual Care Clin Outcomes; 2018 Jan; 4(1):10-17. PubMed ID: 28950310
[TBL] [Abstract][Full Text] [Related]
10. Peripheral arterial disease in diabetic patients: a long-term population-based study on occurrence, outcomes and cost.
Marone EM; Cozzolino P; Ciampichini R; Chiodini V; Ferraresi R; Rinaldi LF; Mantovani LG; Cesana G
J Cardiovasc Surg (Torino); 2018 Aug; 59(4):572-579. PubMed ID: 29745215
[TBL] [Abstract][Full Text] [Related]
11. Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample.
Kohn CG; Alberts MJ; Peacock WF; Bunz TJ; Coleman CI
Atherosclerosis; 2019 Jul; 286():142-146. PubMed ID: 31170647
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: a retrospective cohort study.
Fox KM; Wang L; Gandra SR; Quek RGW; Li L; Baser O
BMC Cardiovasc Disord; 2016 Jan; 16():13. PubMed ID: 26769473
[TBL] [Abstract][Full Text] [Related]
13. The effect of diabetes mellitus on costs and length of stay in patients with peripheral arterial disease undergoing vascular surgery.
Malone M; Lau NS; White J; Novak A; Xuan W; Iliopoulos J; Crozier J; Dickson HG
Eur J Vasc Endovasc Surg; 2014 Oct; 48(4):447-51. PubMed ID: 25116276
[TBL] [Abstract][Full Text] [Related]
14. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
[TBL] [Abstract][Full Text] [Related]
15. Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States.
Mahoney EM; Wang K; Keo HH; Duval S; Smolderen KG; Cohen DJ; Steg G; Bhatt DL; Hirsch AT;
Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):642-51. PubMed ID: 20940249
[TBL] [Abstract][Full Text] [Related]
16. Resource use and costs in high-risk symptomatic peripheral artery disease patients with diabetes and prior acute coronary syndrome: a retrospective analysis.
Reed Chase M; Friedman HS; Navaratnam P; Heithoff K; Simpson RJ
Postgrad Med; 2016; 128(2):170-9. PubMed ID: 26788980
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular outcomes in patients with peripheral arterial disease as an initial or subsequent manifestation of atherosclerotic disease: Results from a Swedish nationwide study.
Sigvant B; Hasvold P; Kragsterman B; Falkenberg M; Johansson S; Thuresson M; Nordanstig J
J Vasc Surg; 2017 Aug; 66(2):507-514.e1. PubMed ID: 28433332
[TBL] [Abstract][Full Text] [Related]
18. Healthcare resource utilization and costs of major atherothrombotic vascular events among patients with peripheral artery disease after revascularization.
Desai U; Kharat A; Hess CN; Milentijevic D; Laliberté F; Zuckerman P; Benson J; Lefebvre P; Hiatt WR; Bonaca MP
J Med Econ; 2021; 24(1):402-409. PubMed ID: 33634723
[TBL] [Abstract][Full Text] [Related]
19. Estimated annual health care expenditures in individuals with peripheral arterial disease.
Scully RE; Arnaoutakis DJ; DeBord Smith A; Semel M; Nguyen LL
J Vasc Surg; 2018 Feb; 67(2):558-567. PubMed ID: 28847660
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of sarcoidosis in a commercially-insured population in the United States.
Rice JB; White A; Lopez A; Conway A; Wagh A; Nelson WW; Philbin M; Wan GJ
J Med Econ; 2017 Oct; 20(10):1048-1055. PubMed ID: 28678623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
